H ARVEY CUSHING first described a patient with the disease bearing his name in 1912 (1).
The patient manifested rapidly acquired central obesity, hypertrichosis, amenorrhea, and …

Objective: To review the main pharmacological properties and clinical applications of the
drugs used in the medical therapy of Cushing's syndrome. Data Sources: Search for articles …

The clinical characteristics and current concepts of pathophysiology of Cushing's syndrome
are reviewed. The specific type of pituitary or ACTH-dependent and ACTH-independent …

We designed a systematic study of patients with Cushing's disease to compare the results of
acute experiments with cyproheptadine, sodium valproate and bromocriptine with the results …

Cyproheptadine and bromocriptine have been reported to be therapeutic in suppressing
ACTH levels in Cushing's disease and Nelson's syndrome. However, there have been only …

Four patients with proved Cushing's disease underwent spontaneous clinical and
biochemical remission. They were part of an 11-patient group treated with methods that …

Cyproheptadine, a nonselective 5-hydroxytryptamine receptor blocking agent, reduces
ACTH and ß-endorphin secretion from the ACTH-producing tumors. A 35-year-old female …

A 60-year-old woman with an 8-year history of Cushing's syndrome was evaluated.
Biochemical data were consistent with those of Cushing's disease. Plasma ACTH levels …

Secondary hypertension (HTN) is HTN for which an underlying cause can be identified. In
childhood, this constitutes a significant proportion of HTN requiring treatment. This is in …

Tratamiento farmacológico del síndrome de Cushing SciELO - Scientific Electronic Library
Online vol.38 número1 Marcadores biológicos para el diagnóstico y tratamiento del asma …